Formulation And Evaluation Of Topical Microemulsion Of Smilax China

The study’s objective was to create a unique Smilax China microemulsion medication delivery method for topical use. To prepare the optimal solvent system for the new formulation, methanolic extraction of dried rhizomes from Smilax china will be performed in order to determine the key ingredients present (which will be employed in formulation) and to determine the drug’s solubility with various excipients. To assess the standby status of the formulation using several metrics. To make the medication more soluble and permeable so that it can be applied topically without causing any negative side effects from the drug’s first pass action, also known as hepatic first pass metabolism. The present study focuses on the formulation and evaluation of a topical microemulsion of Smilax china, a medicinal plant renowned for its anti-inflammatory and antioxidant properties. The primary aim is to develop a stable microemulsion system that enhances the percutaneous delivery of active phytoconstituents from Smilax china for effective topical application. The formulation was optimized using various ratios of surfactants, co-surfactants, oil phase, and water phase, determined by constructing pseudoternary phase diagrams. The optimized microemulsion was evaluated for particle size, zeta potential, viscosity, and pH, along with in vitro drug release and ex vivo skin permeation studies using Franz diffusion cells. Stability tests, including centrifugation, and accelerated stability studies, were conducted to ensure the long-term viability of the formulation. The developed microemulsion demonstrated excellent physical stability, improved skin permeation, and significant anti-inflammatory effects, making it a promising candidate for topical therapeutic applications.